Brief: First Nasally-Administered Pharmaceutical Treatment For Dry Eye Disease Approved By Us FDA With Aptar’S Nasal Pump System
25/10/2021 13:45
Oct 25 (Reuters) - Aptargroup Inc ATR.N :
* FIRST NASALLY-ADMINISTERED PHARMACEUTICAL TREATMENT FOR
DRY EYE
DISEASE APPROVED BY US FDA WITH APTAR’S NASAL PUMP SYSTEM
Source text for Eikon: ID:nBw9lkd0ba
Further company coverage: ATR.N
Recent news on AptarGroup
See all newsBrief: Aptargroup Note Decree Of President Of Russian Federation
Russia puts Aptar Europe Holding under temporary administration
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Aptargroup Inc reports results for the quarter ended June 30 - Earnings Summary
Aptar Q2 sales beat estimates on strength in consumer healthcare and injectables